Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer

Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antimicrobial Agents and Chemotherapy 1995-02, Vol.39 (2), p.445-452
Hauptverfasser:	Cometta, A, Zinner, S, de Bock, R, Calandra, T, Gaya, H, Klastersky, J, Langenaeken, J, Paesmans, M, Viscoli, C, Glauser, M P
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Agranulocytosis Agranulocytosis - drug therapy Amikacin Amikacin - therapeutic use Ceftazidime Ceftazidime - therapeutic use Child Child, Preschool Clinical Trial Drug Therapy, Combination Drug Therapy, Combination - adverse effects Drug Therapy, Combination - therapeutic use Female Fever Fever - drug therapy Humans Infant Male Middle Aged Neoplasms Neoplasms - complications Neoplasms - drug therapy Penicillanic Acid - analogs & derivatives Penicillanic Acid - therapeutic use Piperacillin - therapeutic use Piperacillin, Tazobactam Drug Combination Prospective Studies Randomized Controlled Trial Research Support, Non-U.S. Gov't
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!